Trial intelligence / Profile preview

Long-term follow-up of HPV16 E6/E7 synthetic long peptide vaccination in women with HPV16-positive VIN

NL-OMON36101Recruiting

Sponsor
Leiden University Medical Center
Start
Sep 2011
Modality
Vaccines & Immunotherapeutics, Peptides
Countries
1
01

Overview

Trial of hpv16 e6/e7 synthetic long peptide vaccine, sponsored by Leiden University Medical Center. Started Sep 2011; status: recruiting.

02

Drugs

hpv16 e6/e7 synthetic long peptide vaccine

Beyond the preview

Go deeper on NL-OMON36101.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON36101.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call